Quick Takeaways
- RNXT - RenovoRx, Inc. has 16 insiders with reported activity on this page.
- Net insider value flow over the last year: +$103,433.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 16 Insiders of RenovoRx, Inc.
- Symbol
- RNXT on Nasdaq
- Location
- Mountain View, CA
What Changed
- Buy value: $103,433; sell value: $0.
- Net share flow: +105,000.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$103,433.
Buys
$103,433
Shares: 105,000
Insiders: 2
Sells
$0
Shares: 0
Insiders: 0
Net
+$103,433
Shares: +105,000
Insiders: 2
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 74,000 | 0 | $64,737 | $0 | +$64,737 |
| 6-9 | 10,000 | 0 | $9,296 | $0 | +$9,296 |
| 9-12 | 21,000 | 0 | $29,400 | $0 | +$29,400 |
RenovoRx, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Kamran Najmabadi | 10%+ Owner | $1,029,324 | Mixed | 25 Aug 2021 | ||
| BANK OF THE WEST | 10%+ Owner | $1,018,875 | Mixed | 16 Mar 2022 | ||
| Ramtin Agah | Chief Medical Officer, Director | $796,463 | +$85,368 | +12% | Filing P/S | 03 Apr 2026 |
| Shaun Bagai | Chief Executive Officer, Director | $306,081 | +$18,065 | +6.3% | Mixed | 03 Apr 2026 |
| Mark Voll | Chief Financial Officer | $180,267 | Mixed | 03 Apr 2026 | ||
| Paul Manners | Chief Financial Officer | $24,383 | Mixed | 25 Aug 2021 | ||
| Laurence Marton | Director | $18,089 | Mixed | 20 Mar 2026 | ||
| Ron Kocak | VP, Controller and PAO | $9,950 | Filing P/S | 01 Jul 2025 | ||
| Angela Gill Nelms | Chief Operating Officer | $1,150 | Filing P/S | 19 Jan 2024 | ||
| Christopher J. Lehman | Chief Financial Officer | Mixed | 30 Aug 2021 | |||
| Robert J. Spiegel | Director | Mixed | 01 Oct 2025 | |||
| James M. Ahlers | Chief Financial Officer | Mixed | 15 Jul 2022 | |||
| K. Angela Macfarlane | Director | Mixed | 01 Oct 2025 | |||
| David Diamond | Director | Mixed | 01 Oct 2023 | |||
| Una S. Ryan | Director | Mixed | 01 Oct 2025 | |||
| Leesa Gentry | Chief Clinical Officer | Mixed | 03 Apr 2026 |
Top shareholders of RenovoRx, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Orin Hirschman |
13D/G
|
AIGH Capital Management LLC |
9.8%
|
4,430,493
|
$4,474,798 | +$1,833,453 | 31 Mar 2026 | |
| AIGH Capital Management LLC |
13F
|
Company |
6.3%
|
2,833,894
|
$3,671,068 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
1,605,079
|
$1,348,267 | — | 31 Dec 2025 | |
| AWM Investment Company, Inc. |
13D/G
|
— |
2.4%
|
863,790
|
$1,097,013 | -$1,278,172 | 30 Sep 2025 | |
| Kamran Najmabadi |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
985,000
|
$1,029,324 | — | 25 Aug 2021 | |
| BANK OF THE WEST |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
975,000
|
$1,018,875 | — | 16 Mar 2022 | |
| Ramtin Agah |
3/4/5
|
Chief Medical Officer, Director |
—
mixed-class rows
|
1,420,187
mixed-class rows
|
$796,463 | +$85,368 | 03 Apr 2026 | |
| Bleichroeder LP |
13F
|
Company |
1.3%
|
600,000
|
$504,060 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.82%
|
371,393
|
$312,024 | — | 31 Dec 2025 | |
| Shaun Bagai |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
1,322,597
mixed-class rows
|
$306,081 | +$18,065 | 03 Apr 2026 | |
| Wealthspire Advisors, LLC |
13F
|
Company |
0.56%
|
252,525
|
$212,147 | — | 31 Dec 2025 | |
| Mark Voll |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
263,180
mixed-class rows
|
$180,267 | — | 03 Apr 2026 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.26%
|
117,457
|
$98,676 | — | 31 Dec 2025 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.2%
|
92,356
|
$91,968 | — | 31 Dec 2025 | |
| NIXON PEABODY TRUST CO |
13F
|
Company |
0.21%
|
97,165
|
$81,628 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.2%
|
90,009
|
$75,617 | — | 31 Dec 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.17%
|
74,616
|
$62,685 | — | 31 Dec 2025 | |
| Caprock Group, LLC |
13F
|
Company |
0.14%
|
63,940
|
$53,716 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
53,408
|
$44,868 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.11%
|
50,140
|
$42,123 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
42,161
|
$35,419 | — | 31 Dec 2025 | |
| Kestra Advisory Services, LLC |
13F
|
Company |
0.08%
|
35,520
|
$29,840 | — | 31 Dec 2025 | |
| Paul Manners |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
23,333
|
$24,383 | — | 25 Aug 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
26,152
|
$21,970 | — | 31 Dec 2025 | |
| Laurence Marton |
3/4/5
|
Director |
—
mixed-class rows
|
128,384
mixed-class rows
|
$18,089 | — | 20 Mar 2026 | |
| Cypress Point Wealth Management, LLC |
13F
|
Company |
0.04%
|
20,000
|
$16,802 | — | 31 Dec 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.04%
|
20,000
|
$16,802 | — | 31 Dec 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.04%
|
19,649
|
$16,507 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
13,905
|
$11,682 | — | 31 Dec 2025 | |
| Ground Swell Capital, LLC |
13F
|
Company |
0.03%
|
13,611
|
$11,435 | — | 31 Dec 2025 | |
| Affinity Capital Advisors, LLC |
13F
|
Company |
0.03%
|
13,279
|
$11,156 | — | 31 Dec 2025 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.03%
|
12,307
|
$10,339 | — | 31 Dec 2025 | |
| Ron Kocak |
3/4/5
|
VP, Controller and PAO |
—
mixed-class rows
|
54,195
mixed-class rows
|
$9,950 | — | 01 Jul 2025 | |
| Cetera Investment Advisers |
13F
|
Company |
0.02%
|
11,000
|
$9,241 | — | 31 Dec 2025 | |
| Focus Partners Wealth |
13F
|
Company |
0.02%
|
11,000
|
$9,241 | — | 31 Dec 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.02%
|
10,726
|
$9,000 | — | 31 Dec 2025 | |
| Capital Advisors Wealth Management, LLC |
13F
|
Company |
0.02%
|
10,000
|
$8,401 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
6,362
|
$5,345 | — | 31 Dec 2025 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.01%
|
3,700
|
$3,000 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
2,279
|
$1,915 | — | 31 Dec 2025 | |
| Angela Gill Nelms |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
126,232
mixed-class rows
|
$1,150 | — | 19 Jan 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,121
|
$942 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
306
|
$257 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Dec 2025 | |
| Leesa Gentry |
3/4/5
|
Chief Clinical Officer |
—
class O/S missing
|
128,550
|
— | — | 03 Apr 2026 | |
| K. Angela Macfarlane |
3/4/5
|
Director |
—
class O/S missing
|
47,640
|
— | — | 01 Oct 2025 | |
| Robert J. Spiegel |
3/4/5
|
Director |
—
class O/S missing
|
47,640
|
— | — | 01 Oct 2025 | |
| Una S. Ryan |
3/4/5
|
Director |
—
class O/S missing
|
47,640
|
— | — | 01 Oct 2025 | |
| David Diamond |
3/4/5
|
Director |
—
class O/S missing
|
25,099
|
— | — | 01 Oct 2023 |
Recent Insider Transactions by Companies or Individuals for RenovoRx, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Shaun Bagai | RNXT | Stock Option | Award | 946,107 | 946,107 | 03 Apr 2026 | Direct | |||
| Mark Voll | RNXT | Common Stock | Award | 214% | 80,000 | 117,380 | 03 Apr 2026 | Direct | ||
| Leesa Gentry | RNXT | Stock Option | Award | 128,550 | 128,550 | 03 Apr 2026 | Direct | |||
| Ramtin Agah | RNXT | Stock Option | Award | 621,727 | 621,727 | 03 Apr 2026 | Direct | |||
| Mark Voll | RNXT | Common Stock | Award | 49.5% | 12,380 | 37,380 | 25 Mar 2026 | Direct | ||
| Laurence Marton | RNXT | Common Stock | Purchase | 9,720 | 9,720 | 20 Mar 2026 | Laurence Marton Rollover IRA | |||
| Laurence Marton | RNXT | Warrants | Purchase | 4,860 | 4,860 | 20 Mar 2026 | Laurence Marton Rollover IRA | |||
| Shaun Bagai | RNXT | Common Stock | Purchase | 8.41% | 24,300 | 313,357 | 20 Mar 2026 | The Bagai Family Trust | ||
| Shaun Bagai | RNXT | Warrants | Purchase | 12,150 | 12,150 | 20 Mar 2026 | The Bagai Family Trust | |||
| Mark Voll | RNXT | Common Stock | Purchase | 97,200 | 97,200 | 20 Mar 2026 | Voll Family Trust DTD 6/23/2010 Mark Voll TTEE | |||
| Mark Voll | RNXT | Warrants | Purchase | 48,600 | 48,600 | 20 Mar 2026 | Voll Family Trust DTD 6/23/2010 Mark Voll TTEE | |||
| Ramtin Agah | RNXT | Common Stock | Purchase | 1.27% | $9,975 | $0.9975 | 10,000 | 798,460 | 21 Jan 2026 | Direct |
| Ramtin Agah | RNXT | Common Stock | Purchase | 1.26% | $8,424 | $0.8600 | 9,795 | 788,460 | 31 Dec 2025 | Direct |
| Ramtin Agah | RNXT | Common Stock | Purchase | 0.03% | $169 | $0.8260 | 205 | 778,665 | 30 Dec 2025 | Direct |
| Shaun Bagai | RNXT | Common Stock | Purchase | 1.49% | $4,506 | $0.9013 | 5,000 | 340,040 | 18 Dec 2025 | Direct |
| Shaun Bagai | RNXT | Common Stock | Purchase | 1.51% | $4,262 | $0.8524 | 5,000 | 335,040 | 17 Dec 2025 | Direct |
| Ramtin Agah | RNXT | Common Stock | Purchase | 1.57% | $10,200 | $0.8500 | 12,000 | 778,460 | 16 Dec 2025 | Direct |
| Ramtin Agah | RNXT | Common Stock | Purchase | 1.32% | $9,600 | $0.9600 | 10,000 | 766,460 | 05 Dec 2025 | Direct |
| Ramtin Agah | RNXT | Common Stock | Purchase | 1.61% | $9,600 | $0.8000 | 12,000 | 756,460 | 24 Nov 2025 | Direct |
| Ramtin Agah | RNXT | Common Stock | Purchase | 1.36% | $8,000 | $0.8000 | 10,000 | 744,460 | 21 Nov 2025 | Direct |
| Laurence J. Marton | RNXT | Stock Options (right to buy) | Award | 47,640 | 47,640 | 01 Oct 2025 | Direct | |||
| K. Angela Macfarlane | RNXT | Stock Options (right to buy) | Award | 47,640 | 47,640 | 01 Oct 2025 | Direct | |||
| Una S. Ryan | RNXT | Stock Options (right to buy) | Award | 47,640 | 47,640 | 01 Oct 2025 | Direct | |||
| Robert J. Spiegel | RNXT | Stock Options (right to buy) | Award | 47,640 | 47,640 | 01 Oct 2025 | Direct | |||
| Shaun Bagai | RNXT | Common Stock | Purchase | 1.54% | $4,549 | $0.9098 | 5,000 | 330,040 | 25 Aug 2025 | Direct |
| Shaun Bagai | RNXT | Common Stock | Purchase | 1.56% | $4,748 | $0.9495 | 5,000 | 325,040 | 22 Aug 2025 | Direct |
| Ramtin Agah | RNXT | Stock Option | Award | 63,636 | 63,636 | 01 Jul 2025 | Direct | |||
| Shaun Bagai | RNXT | Stock Option | Award | 102,498 | 102,498 | 01 Jul 2025 | Direct | |||
| Leesa Gentry | RNXT | Stock Option | Award | 6,619 | 6,619 | 01 Jul 2025 | Direct | |||
| Ron Kocak | RNXT | Stock Option | Award | 41,600 | 41,600 | 01 Jul 2025 | Direct | |||
| Ramtin Agah | RNXT | Common Stock | Purchase | 2.94% | $29,400 | $1.40 | 21,000 | 734,460 | 05 Jun 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.